Metrifonate and dichlorvos: Effects of a single oral administration on cholinesterase activity in rat brain and blood

Neurochemical Research

Volumn 21, Issue 3, 1996, Pages 339-345

  Hinz, V ^a   Grewig, S ^a   Schmidt, B H ^a  

^a MEDA Manufacturing GmbH   (Germany)

Author keywords

Alzheimer's disease; blood; cholinesterase inhibition; dichlorvos; in vivo; metrifonate; oral administration; rat, brain

Indexed keywords

CHOLINESTERASE; CHOLINESTERASE INHIBITOR; DICHLORVOS; METRIFONATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLINESTERASE BLOOD LEVEL; CHOLINESTERASE INHIBITION; ENZYME ACTIVITY; ENZYME ANALYSIS; INHIBITION KINETICS; MALE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ADMINISTRATION, ORAL; ANIMALS; BRAIN; CHOLINESTERASE INHIBITORS; CHOLINESTERASES; DICHLORVOS; KINETICS; MALE; RATS; RATS, WISTAR; TIME FACTORS; TRICHLORFON;

ANIMALIA;

EID: 0029863987     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02531650     Document Type: Article

References (40)

1. Sayetta, R. B. 1986. Rates of senile dementia, Alzheimer's type, in the Baltimore Longitudinal Study. J. Chronic Dis. 4:271-286.
2. Robertson, A. 1990. The politics of Alzheimer's disease: a case study in apocalyptic demography. Int. J. Health Serv. 20:429-442.
3. Davies, P., and Maloney, A. 1976. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 2:1403.
4. Whitehouse P. J., Price, D. L., Struble, R. G., Clark, A. W. Coyle J. T., and Delong, M. R. 1982. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science 215: 1237-1239.
5. Perry, E. K., Tomlinson, E., Blessed, G., Bergmann, K., Gibson, P. H., and Perry, R. H. 1978. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br. J. Med. 42:1457-1459.
6. Reisine, T., Yamamura, H. I., Bird, E. D., Spokes, E., and Enna, S. J. 1978. Pre- and postsynaptic neurochemical alterations in Alzheimer's disease. Brain Res. 159:477-481.
7. Zubenko, G. S., Moossey, J., Martinez, A. J., Rao, G. R., Kopp, U., and Hanin, I. 1989. A brain regional analysis of morphologic and cholinergic abnormalities in Alzheimer's disease. Arch. Neurol. 46:634-638.
8. Mash, D. C., Flynn, D. D., and Potter, L. T. 1985. Loss of M2 muscarinic receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation. Science 228:1115-1117.
9. Whitehouse, P. J., Martino, A. M., Wagster, M. V., Price, D. L., Mayeux, R., Atack, J. R., and Kellar, K. J. 1988. Reductions in 3H-nicotinic acetylcholine binding in Alzheimer's disease and Parkinson's disease - an autoradiographic study. Neurology 38: 720-723.
10. Giacobini, E., DeSarno, P., Clark, B., and McIlhany, M. 1989. The cholinergic receptor system of the human brain. Neurochemical and pharmacological aspects in aging and Alzheimer's disease. Pages 335-343, in Nordberg, A. (ed.), Progress in Brain Research, Elsevier, Amsterdam.
11. Richter, J. A., Perry, E. K., and Tomlinson, B. E. 1980. Acetylcholine and choline levels in post-mortem human brain tissue: preliminary observations in Alzheimer's disease. Life Sci. 26: 1683-1689.
12. Bierer, L. M., Haroutunian, V., Gabriel, S., Knott, P. J., Carlin, L. S., Purohit, D. P., Perl, D. P., Schmeidler, J., Kanof, P., and Davis, K. 1995. Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits. J. Neurochem. 64:749-760.
13. Kumar, V., and Becker, R. E. 1989. Clinical pharmacology of tetrahydroaminoacridine: a possible therapeutic agent for Alzheimer's disease. Int. J. Clin. Pharmacol. Ther. Toxicol. 27:478-485.
14. Schneider, L. S. 1993. Clinical pharmacology of aminoacridines in Alzheimer's disease. Neurology 43:64-79.
15. Suha, A., Beller, S. A., Overall, J. E., and Swann, A. C. 1985. Efficacy of oral physostigmine in primary degenerative dementia. A double blind study of response to different dose levels. Psychopharmacology 87:147-151.
16. Becker, R. E., Giacobini, E., Elble, R., Mcllhany, M., and Sherman, K. 1988. Potential pharmacotherapy of Alzheimer's disease. A comparison of various forms of physostigmine administration. Acta Neurol. Scand. Suppl. 116:19-32.
17. Becker, R. E., and Giacobini, E., 1988. Mechanisms of cholinesterase inhibition in senile dementia of the Alzheimer type: clinical, pharmacological, and therapeutic aspects. Drug Dev. Res. 12: 163-195.
18. Giacobini, E., 1991. The second generation of cholinesterase inhibitors: pharmacological aspects. Pages 247-262, in Becker, R. and Giacobini, E. (eds.), Cholinergic Basis for Alzheimer Therapy, Birkhauser, Boston.
19. Spiegel, R., Enz, A., Meier, D., and Emre, M. 1994. The cholinergic approach in ATD: Focus on international multicentre drug study. Neuropsychopharmacology 10:7355.
20. Moskovskij, N. I., Grigorieva, I. V., and Sokolchik, E. I. 1991. The efficacy of amiridine in Alzheimer's type senile dementia. Zh. Nevropatol. Psikhiatr. Im. S. S. Korsakova 91:53-55.
21. Sherman, K. A. 1991. Pharmacodynamics of oral E2020 and tacrine in humans: novel approaches. Pages 321-329, in Becker, R. and Giacobini, E. (eds.), Cholinergic Basis for Alzheimer Therapy, Birkhauser, Boston.
22. Holmstedt, B., Nordgren, I., Sandoz, M., and Sundwall, A. 1978. Metrifonate: Summary' of toxicological and pharmacological information available. Arch. Toxicol. 41:3-29.
23. Reiner, E., Krauthacker, B., Simeon, V., and Skrinjaric-Spoljar, M, 1975. Mechanism of inhibition in vitro of mammalian acetylcholinesterase and cholinesterase in solutions of 0,0-dimethyl 2,2,2-trichloro-1-hydroxyethyl phosphonate (Trichlorfon). Biochem. Pharmacol. 24:717-722.
24. Nordgren, I., Bergström, M., Holmstedt, B., and Sandoz, M. 1978. Transformation and action of Metrifonate. Arch. Toxicol. 41, 31-41.
25. Ellman, G. L., Courtney, K. D., Andres, V. Jr., and Featherstone, R. M. 1961. A new, rapid calorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7:88-95.
26. Dixon, W. J. 1959. Analysis of extreme values. Annals of Mathematical Statistics 21:488-506.
27. Dixon, W. J. 1959. Ratios involving extreme values. Annals of Mathematical Statistics 22:68-78.
28. Blokland, A., Hinz, V., and Schmidt, B. 1995. Effects of metrifonate and tacrine in the spatial Morris maze task and modified Irwin test: Evaluation of the efficacy/safety profile in rats. Drug Dev. Res.: in press.
29. Soininen, H. S., Unni, I., and Shillcutt, S. 1990. Effect of acute and chronic cholinesterase inhibition on biogenic amines in rat brain. Neurochem. Res. 15:1185-1190.
30. Hallak, M., and Giacobini, E. 1989. Physostigmine, tacrine and metrifonate: the effect of multiple doses on acetylcholine metabolism in rat brain. Neuropharmacol. 28:199-206.
31. Jewsbury, J. M. 1981. Metrifonate in schistosomiasis-therapy and prophylaxis. Acta Pharmacol. Toxicol. 49:123-130.
32. Hinz, V. C., Grewig, S., and Schmidt, B. H. 1995. Metrifonate induces cholinesterase inhibition exclusively via slow release of dichlorvos. Naunyn Schmiedeberg's Arch. Pharmacol. 351(S): R135.
33. Main, A. R. 1979. Mode of action of anticholinesterases. Pharmacol. Ther. 6:579-628.
34. Modak, A. T., Stavinoha, W. B., and Weintraub, S. T. 1975. Dichlorvos and the cholinergic system: effects on cholinesterase and acetylcholinesterase and choline contents of rat tissue. Arch. Int. Pharmacodyn. 217:293-301.
35. Reiner, E., and Pleština, R. 1979. Regeneration of cholinesterase activities in humans and rats after inhibition of 0,0-dimethyl 2,2-dichlorovinyl phosphate. Toxicol. Appl. Pharmacol. 49:451-454.
36. Sterri, S. H. 1981. Factors modifying the toxicity of organophosphorous compounds including dichlorvos. Acta Pharmacol. Toxicol. 49:67-71.
37. Blair, D., Hoadley, E. C., and Hutson, D. H. 1975. The distribution of dichlorvos in the tissues of mammals after its inhalation or intravenous administration. Toxicol. Appl. Pharmacol. 31:243-253.
38. Hallak, M., and Giacobini, E. 1987. A comparison of the effects of two inhibitors on brain cholinesterase. Neuropharmacology 26: 521-530.
39. DuBois, K. P., and Cotter, G. J. 1955. Studies on the toxicity and mechanism of action of dipterex. Arch. Industr. Health 11:53-60.
40. Arthur, B. W., and Casida, J. E. 1957. Mode of action of insecticides. Metabolism and selectivity of 0,0-dimethyl 2,2,2-trichloro1-hydroxyethyl phosphonate and its acetyl and vinyl derivatives. J. Agric. Food Chem. 5:186-192.